Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RLYB | Common Stock | Purchase | $24.1K | +3K | +6.81% | $8.04 | 47K | Mar 21, 2022 | See Footnote | F1, F2 |
holding | RLYB | Common Stock | 273K | Mar 21, 2022 | See Footnote | F3 | |||||
holding | RLYB | Common Stock | 202K | Mar 21, 2022 | See Footnote | F4 | |||||
holding | RLYB | Common Stock | 202K | Mar 21, 2022 | See Footnote | F5 |
Id | Content |
---|---|
F1 | The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.00 to $8.99, inclusive. The reporting person undertakes to provide to Rallybio Corporation, any security holder of Rallybio Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4. |
F2 | Shares of common stock are held in a Roth IRA. |
F3 | Shares of common stock are held in a revocable trust for which Mr. Fryer is the grantor. |
F4 | Shares of common stock are held in an irrevocable trust for the benefit of one of Mr. Fryer's children. Mr. Fryer disclaims beneficial ownership of such shares. |
F5 | Shares of common stock are held in an irrevocable trust for the benefit of one of Mr. Fryer's children. Mr. Fryer disclaims beneficial ownership of such shares. |
Chief Financial Officer & Treasurer